Matthew Richard Moore
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Austin Rutherford, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Matthew Richard Moore:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | SVP and Chief Business Officer | Common Stock | 145,505 | $1,271,394 | $8.74 | 02 May 2024 | Direct |
| Arcutis Biotherapeutics, Inc. | SVP and Chief Business Officer | Stock Option (Right to Buy) | 0 | 13 Feb 2024 | Direct | ||
| Ventyx Biosciences, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 0 | 04 Mar 2026 | Direct |
Insider Reports Filed by Matthew Richard Moore
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VTYX | Ventyx Biosciences, Inc. | 04 Mar 2026 | 2 | $0 | 4 | Chief Operating Officer | 04 Mar 2026, 16:30 |
| VTYX | Ventyx Biosciences, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Chief Operating Officer | 03 Jan 2025, 18:53 |
| VTYX | Ventyx Biosciences, Inc. | 16 May 2024 | 1 | $0 | 4 | Chief Operating Officer | 17 May 2024, 16:20 |
| VTYX | Ventyx Biosciences, Inc. | 16 May 2024 | 0 | $0 | 3 | Chief Operating Officer | 17 May 2024, 16:19 |
| ARQT | Arcutis Biotherapeutics, Inc. | 01 May 2024 | 2 | -$40,902 | 4 | SVP and Chief Business Officer | 03 May 2024, 16:29 |
| ARQT | Arcutis Biotherapeutics, Inc. | 04 Mar 2024 | 1 | -$38,568 | 4 | SVP and Chief Business Officer | 06 Mar 2024, 17:08 |
| ARQT | Arcutis Biotherapeutics, Inc. | 13 Feb 2024 | 10 | $0 | 4 | SVP and Chief Business Officer | 15 Feb 2024, 18:47 |
| ARQT | Arcutis Biotherapeutics, Inc. | 12 Jan 2024 | 2 | $0 | 4 | SVP and Chief Business Officer | 17 Jan 2024, 16:28 |
| ARQT | Arcutis Biotherapeutics, Inc. | 29 Aug 2023 | 1 | $0 | 4 | SVP and Chief Business Officer | 12 Sep 2023, 07:39 |
| ARQT | Arcutis Biotherapeutics, Inc. | 02 Mar 2023 | 4 | -$25,481 | 4 | Reporting Person's title: Senior Vice President and Chief Business Officer | 06 Mar 2023, 17:54 |
| ARQT | Arcutis Biotherapeutics, Inc. | 03 Mar 2022 | 2 | $0 | 4 | SVP and Chief Business Officer | 07 Mar 2022, 19:46 |